Our results highlighted the importance of the PNPLA3 genotype and FIB-4 index ≥ 2.67 on the incidence of complications in Japanese patients with NAFLD, especially the incidence of CVDs. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.